Cardiovascular Revascularization Medicine
Volume 10, Issue 2 , Pages 94-102 , April 2009

Drug-eluting or bare-metal stents in subjects over 75 years of age: what is the best therapeutic strategy? Data from 460 consecutive patients with 1-year outcome

  • Horma Ouldzein

      Affiliations

    • Cardiology Federation, Toulouse-Rangueil University Hospital, TSA 50032, 31059 Toulouse Cedex 9, France
    • ,
  • Jérome Roncalli

      Affiliations

    • Cardiology Federation, Toulouse-Rangueil University Hospital, TSA 50032, 31059 Toulouse Cedex 9, France
    • ,
  • Walid Zouaoui

      Affiliations

    • Cardiology Federation, Toulouse-Rangueil University Hospital, TSA 50032, 31059 Toulouse Cedex 9, France
    • ,
  • Vanina Bongard

      Affiliations

    • Department of Epidemiology, Centre Hospitalier Universitaire de Toulouse & INSERM U558, France
    • ,
  • Nicolas Boudou

      Affiliations

    • Cardiology Federation, Toulouse-Rangueil University Hospital, TSA 50032, 31059 Toulouse Cedex 9, France
    • ,
  • Nicolas Dumonteil

      Affiliations

    • Cardiology Federation, Toulouse-Rangueil University Hospital, TSA 50032, 31059 Toulouse Cedex 9, France
    • ,
  • Thibaut Lhermusier

      Affiliations

    • Cardiology Federation, Toulouse-Rangueil University Hospital, TSA 50032, 31059 Toulouse Cedex 9, France
    • ,
  • Meyer Elbaz

      Affiliations

    • Cardiology Federation, Toulouse-Rangueil University Hospital, TSA 50032, 31059 Toulouse Cedex 9, France
    • ,
  • Jacques Puel

      Affiliations

    • Cardiology Federation, Toulouse-Rangueil University Hospital, TSA 50032, 31059 Toulouse Cedex 9, France
    • Deceased.
    • ,
  • Didier Carrié

      Affiliations

    • Cardiology Federation, Toulouse-Rangueil University Hospital, TSA 50032, 31059 Toulouse Cedex 9, France
    • Corresponding Author InformationCorresponding author. Hôpital de Rangueil, Service de cardiologie B, TSA 50032, 31059 Toulouse Cedex 9, France. Tel.: +33 561323454; fax: +33 561323325.

Received 22 September 2008 ,Revised 25 November 2008 ,Accepted 1 December 2008.

References 

  1. Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart. 2006;92:641–649
  2. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, et al. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol. 2007;99:333–338
  3. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:1030–1039
  4. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:989–997
  5. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351
  6. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969[Erratum in: J Am Coll Cardiol 2001; 37: 973]
  7. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020–1029
  8. Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non–Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 1999;100:1593–1601
  9. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. Randomized study with the sirolimus-Coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
  10. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  11. Schofer J, Schlüter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093–1099
  12. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788–794
  13. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–231
  14. Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation. 2005;111:2326–2329
  15. Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation. 2005;111:1040–1041
  16. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294:1215–1223
  17. Schampaert E, Moses JW, Schofer J, Schlüter M, Gershlick AH, Cohen EA, et al. Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. Am J Cardiol. 2006;98:36–41
  18. Ong AT, van Domburg RT, Aoki J, Sonnenschein K, Lemos PA, Serruys PW. Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol. 2006;47:1356–1360
  19. Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol. 2006;48:32–36
  20. Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, et al. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation. 2007;115:3181–3188
  21. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998–1008
  22. Biondi-Zoccai GG, Agostoni P, Abbate A, Testa L, Burzotta F, Lotrionte M, et al. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials. Int J Cardiol. 2005;100:119–123
  23. Bernardi V, Szarfer J, Summay G, Mendiz O, Sarmiento R, Alemparte MR, et al. Long-term versus short-term clopidogrel therapy in patients undergoing coronary stenting (from the Randomized Argentine Clopidogrel Stent [RACS] trial). Am J Cardiol. 2007;99:349–352
  24. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527–533
  25. Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C, et al. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411–2420
  26. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706–1717
  27. Assmus B, Walter DH, Britten MB, Fichtlscherer S, Auch-Schwelk W, Zeiher , et al. Coronary stent implantation in elderly patients: acute and long-term results. Z Kardiol. 2003;92:633–640
  28. Batchelor WB, Anstrom KJ, Muhlbaier LH, Grosswald R, Weintraub WS, O'Neill WW, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol. 2000;36:723–730
  29. Klein LW, Block P, Brindis RG, McKay CR, McCallister BD, Wolk M, et al. Percutaneous coronary interventions in octogenarians in the American College of Cardiology-National Cardiovascular Data Registry: development of a nomogram predictive of in-hospital mortality. J Am Coll Cardiol. 2002;40:394–402
  30. Hassani SE, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, Suddath WO, et al. Percutaneous coronary intervention with drug-eluting stents in octogenarians: characteristics, clinical presentation, and outcomes. Catheter Cardiovasc Interv. 2006;68:36–43
  31. Cohen HA, Williams DO, Holmes DR, Selzer F, Kip KE, Johnston JM, et al. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. Am Heart J. 2003;146:513–519
  32. Tedesco JV, Williams BA, Wright RS, Reeder GS, Dvorak D, Kopecky SL, et al. Baseline comorbidities and treatment strategy in elderly patients are associated with outcome of cardiogenic shock in a community-based population. Am Heart J. 2003;146:472–478
  33. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804–847

PII: S1553-8389(08)00297-2

doi: 10.1016/j.carrev.2008.12.001

Cardiovascular Revascularization Medicine
Volume 10, Issue 2 , Pages 94-102 , April 2009

Article Tools

* Image Usage & Resolution